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Abstract
Background: Out of 1.484 billion disability-adjusted life years lost globally in 2008, 369.1 million (25%) were lost in
the WHO African Region. Despite the heavy disease burden, the majority of countries in the Region are not on
track to achieve Millennium Development Goals (MDG) 4 (reducing child mortality), 5 (improving maternal health),
and 6 (combating HIV/AIDS, malaria and other diseases). This article provides an overview of the state of public
health, summarizes 2010-2015 WHO priorities, and explores the role that private sector could play to accelerate
efforts towards health MDGs in the African Region.
Discussion: Of the 752 total resolutions adopted by the WHO Regional Committee for Africa (RC) between years
1951 and 2010, 45 mention the role of the private sector. We argue that despite the rather limited role implied in
RC resolutions, the private sector has a pivotal role in supporting the achievement of health MDGs, and articulating
efforts with 2010-2015 priorities for WHO in the African Region: provision of normative and policy guidance as well
as strengthening partnerships and harmonization; supporting the strengthening of health systems based on the
Primary Health Care approach; putting the health of mothers and children first; accelerating actions on HIV/AIDS,
malaria and tuberculosis; intensifying the prevention and control of communicable and noncommunicable
diseases; and accelerating response to the determinants of health.
Conclusion: The very high maternal and children mortality, very high burden of communicable and non-
communicable diseases, health systems challenges, and inter-sectoral issues related to key determinants of health
are too heavy for the public sector to address alone. Therefore, there is clear need for the private sector, given its
breadth, scope and size, to play a more significant role in supporting governments, communities and partners to
develop and implement national health policies and strategic plans; strengthen health systems capacities; and
implement roadmaps for accelerating the attainment of health MDGs relating to maternal and child health,
reducing disease burden, and promoting social determinants of health.
In order for governments to further explore the potential benefits of the private sector towards improved
performance of health systems, there is need for accurate evidence on the private sector capacity in areas of
prevention, promotion, treatment and rehabilitation; dialogue and negotiation; clear definition of roles and
responsibilities; and regulatory frameworks.
Background
The objectives of this article are to provide an overview
of the state of public health in the 46 countries of the
African Region; summarize 2010-2015 priorities for
WHO in the African Region; analyze the role of the pri-
vate sector as perceived by the WHO Regional Commit-
tee for Africa; and provide the author’sv i e wp o i n t so n
the potential role of the private sector in health
development. The private sector refers to the part of the
economy not under direct state control. In this article,
the working definition of private sector is any private
enterprise, business or businesses not under state con-
trol, i.e. run by private individuals or groups for profit.
Overview of the state of public health
In 2008, the world lost 1.484 billion disability-adjusted
life years (DALYs) from various causes. The WHO Afri-
can Region bore 25% of that burden, while sharing just
12.1% of the world’s population [1]. Of the total DALYs
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causes depicted in Figure 1. HIV/AIDS, lower respira-
tory infections, injuries, malaria and diarrhoeal diseases
accounted for 47% of the DALYs lost in the Region.
In 2000 the world leaders agreed on eight Millennium
Development Goals (MDGs) to address disease, income
poverty, hunger, ignorance, and squalor [2]. The MDGs
4a n d5a r ea b o u th e a l t ho fc h i l d r e na n dw o m e n ,a n d
MDG6 is concerned with control main diseases such as
HIV/AIDS, tuberculosis and malaria. Progress towards
the MDG targets has been uneven in Africa [3].
African Region under-five mortality rate decreased
from 179 per 1000 live births in 1990 to 127 in 2009
[4]. However, it is declining at an average rate of 1.45%
per year, which is slower than the 8% per year needed
to achieve MDG4 by 2015. The key to progress towards
attaining this goal by 2015 is to reach every newborn
and child with priority interventions such as breast feed-
ing; immunization to curb vaccine-preventable diseases;
and prevention and management of common childhood
illnesses such as pneumonia, acute respiratory infections,
diarrhoea, malaria, malnutrition and HIV infection. For
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Figure 1 Top 16 causes of disability adjusted life years (DALYs) loss in WHO African Region, 2008.
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children for the third dose of DPT3 increased in the
African Region from 57% in 1990 to 71% in 2009 [4].
Maternal mortality ratio also decreased from 850 per
100 000 live births in 1990 to 620 in 2008 [4,5]. Most
countries are unlikely to attain the MDG 5A target at
the prevailing low rate of decline in maternal mortality
ratio. Majority of maternal deaths could be averted if
every woman in need had access to quality reproductive
health services such as skilled attendance during preg-
nancy, childbirth and the postnatal period; and emer-
gency obstetric care (EOC) and family planning.
Unfortunately, coverage of skilled birth attendance in
the African Region remains low at 48%, with wide varia-
tion in the rates among countries [4]. Only 44% of preg-
nant women made at least four antenatal care visits in
2010 [4] and even a smaller proportion of pregnant
women in need of EOC got it.
The world leaders committed to halt and reverse the
incidence of HIV/AIDS, Malaria and TB by 2015 as part
of efforts to achieve MDG6. Yet, whereas the African
Region is home to approximately 12% of the world
population, it accounts for two thirds (67.6%) of people
living with HIV/AIDS globally; two thirds (68.2%) of all
new adult HIV infections; 90% of new HIV infections in
children; and 72.2% of AIDS-related deaths [6]. The
number of AIDS-related deaths decreased from 1, 400,
000 in 2001 to 1, 300, 000 in 2009. The number of new
HIV infections per year is on decline on average, but in
general the incidence rate is till very high. Coverage of
primary prevention interventions is low. For example, in
2009 only 33% of Male and 25% of female population
aged 15-24 years had comprehensive correct knowledge
of HIV/AIDS [4]. The prevalence of condom use by
adults aged 15-49 years during higher risk sex is also
low. Coverage of services for the prevention of mother-
to-child transmission was 54% in 2009 [4]. Though
Africa has made significant progress in increasing access
to antiretroviral treatment, there is still large unmet
need.
The African Region also accounts for about a third
(27.9%) of all tuberculosis (TB) cases. The prevalence
rate of TB increased from 450 per 100 000 population
in 2000 to 475 per 100 000 population in 2009; and
incidence of TB increased from 314 per 100 000 popula-
tion in 2000 to 345 per 100 000 population per year [4].
The situation has been exacerbated by the combination
of HIV with TB and increase in prevalence of MDR-TB.
Malaria in Africa represents 85% of all malaria cases;
and 89% of all malaria-related deaths worldwide [7]. In
some countries the battle against malaria is progressing
with growing coverage of vector control using insecti-
cide-treated nets and indoor residual spraying;
artimisinin-based combination therapy; and intermittent
preventive treatment of malaria in pregnancy.
Strategic thrusts for WHO in the African Region
Based on the above overview of the state of public
health in the Region, a number of thrusts were estab-
lished for WHO in the African Region from 2010 to
2015 [8].
Providing normative and policy guidance as well as
strengthening partnerships and harmonization
This entails providing technical support to governments
to develop comprehensive (including the private health
sector) national health policies and costed national
health sector strategic plans [9]. It also includes imple-
menting and monitoring the Paris Declaration on Aid
Effectiveness [10] and the Accra Agenda for Action [11].
Supporting the strengthening of health systems based on
the Primary Health Care approach
This involves supporting countries to implement the
Ouagadougou Declaration [12] on Primary Health Care
and health systems strengthening and the Algiers
Declaration [13] on Research for Health in Africa. The
overall objective is to strengthen leadership and govern-
ance in health; health workforce capacity [14]; adequate
provision and use of medical products, vaccines and
technologies [15,16]; health financing with a view to
strengthening the delivery of health care; and improving
health outcomes [17]. It also involves implementing the
‘Health financing: a strategy of the WHO African
Region’ [18]; and the Seychelles [19] and Cape Verde
[20] Declarations of Ministers of Health of the Small
Island Developing States in the African Region.
Putting the health of mothers and children first
This requires supporting countries to implement the
Roadmap for accelerating the attainment of the MDGs
relating to maternal and newborn health in Africa [21].
It includes defining a minimum package of services at
each level of the health system; assessing needs; and
producing a skilled health workforce for delivery of
quality maternal and child health care. This strategic
direction is also about accelerating the implementation
of the Child Survival Strategy for the African Region
[22].
Accelerating actions on HIV/AIDS, malaria, tuberculosis and
other communicable diseases
This provides accelerated support to countries to
expand coverage of cost-effective interventions into
HIV/AIDS [23-29], tuberculosis [30-32] and malaria
[33-37]. It also includes support to address the burden
of neglected tropical diseases, e.g. dracunculiasis [38],
leprosy [39], lymphatic filariasis, onchocerciasis [40], try-
panosomiasis [41], schistosomiasis, soil-transmitted hel-
minths and trachoma); and to improve systems of early
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countries are supported to comply with the core
requirements of the International Health Regulations
[43].
Intensifying the prevention and control of
noncommunicable diseases
This is about intensifying support to countries to pre-
vent and control the increasing burden of noncommu-
nicable diseases [44] such as cancer [45], diabetes [46],
and cardiovascular diseases, as well as conditions related
to oral health [47], mental health and substance abuse
[48]. It also entails implementation of the regional strat-
egy on Integrated Disease Surveillance and Response
(IDSR), which aims to improve the availability and use
of surveillance and laboratory data for control of priority
infectious diseases [42]; and policy orientations on the
establishment of centres of excellence for disease sur-
veillance, public health laboratories, food and medicines
regulation [49].
Accelerating response to the determinants of health
This concerns implementing the Libreville declaration
on health and environment [50], the Luanda commit-
ment [51] by African Ministers responsible for health
and environment to implement the Libreville declara-
tion, the Nairobi call for action for closing the imple-
mentation gap in health promotion [52], and the
regional strategies on environmental health [53], food
safety [54], health promotion [55], poverty and health
[56], and addressing the key determinants of health in
the African Region [57]. Implementation includes
addressing risk factors such as unhealthy food consump-
tion patterns, harmful use of alcohol, tobacco use,
sedentary lifestyle, and other behavioural challenges.
The prevailing situation can only be changed if gov-
ernments, communities, the private sector and develop-
ment partners work together to accelerate achievement
of the Millennium Development Goals.
Discussion
Analysis of Ministers of Health deliberations on the role
of private sector in health development
Since the WHO Regional Office for Africa was estab-
lished in 1951, the WHO Regional Committee for Africa
has held 60 sessions and adopted 752 resolutions
[58-63]. The number of resolutions increased between
1951 and 1970 but decreased in a sustained manner
since 1971. Of the total resolutions adopted between
1951 and 2010, only 45 (6%) mention the private sector.
Figure 2 shows that during the first 25 years of the
Regional Committee, there was no mention of the pri-
vate sector in any of the 370 resolutions adopted.
The role of the private sector was first mentioned dur-
ing the Regional Committee session in 1976. Over the
following 15 years, from 1976 to 1990, the private sector
was mentioned in nine of the 212 resolutions adopted.
From 1991 to 2005, the role of the private sector was
considered in 31 of the 141 resolutions adopted. During
the last five years, from 2006 to 2010, the private sector
features in five of the 29 resolutions adopted. Since
1976, there was a steady increase in the number of reso-
lutions acknowledging the role of the private sector in
health development in the Region reaching a peak in
the decade 1990-2000. In 2001-2010, the number of
resolutions concerning the private sector decreased
slightly, mainly due to a decreasing trend in the total
number of resolutions adopted by the Committee.
Table 1 shows the areas in which the private sector
has been expected to play a role. Of the 45 resolutions
involving the private sector role in public health, 11
(24%) were on prevention and control of HIV/AIDS,
tuberculosis and malaria; nine (20%) were on commu-
nicable diseases; two (4%) were on noncommunicable
diseases; five (11%) were on family and reproductive
health; eight (18%) were on management of health risk
factors; and ten (22%) were on health systems strength-
ening. The three areas with the highest number of reso-
lutions underscoring the private sector role were HIV/
AIDS, dracunculiasis and health technologies (essential
medicines, vaccines and equipment).
T h eq u e s t i o nr e m a i n sa st ow h yo n l y6 %o ft h e
Regional Committee resolutions pertain, either directly
or indirectly, to the role of the private sector in health
development. One answer may be that most of the
Years 1981-1990, 7
Years 1971-1980, 2
Years 1961-1970, 0
Years 1951-1960, 0
Years 1991-2000, 
21
Years 2001-2010, 
15
Figure 2 Number of Regional Committee resolutions
mentioning the private sector, 1951-2010.
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private sector seems more interested in clinical ser-
vices. Secondly, there may be limited awareness of the
private sector’s potential scope and role in health
development. A third answer could be that health eco-
nomics, a discipline that could have raised awareness
of the private sector role in health development, only
emerged in the mid-1970s. A fourth reply could be
that the private sector has not made an organized
effort to demonstrate its potential capacity to contri-
bute to the public good. These speculations are pre-
sented here for analysis and better understanding of
the current situation.
Potential role of the private sector in expanding
healthcare services
This section provides author’s opinions on the potential
role of the private sector in supporting implementation
of the thrusts/strategies mentioned earlier.
Thrust 1: Providing normative and policy guidance as well
as strengthening partnerships and harmonization
National health policies and national health strategic
plans ought to encompass the public, nongovernmental
organization and private health sectors. At both devel-
opment and revision stages, private service providers,
through their associations, can work with national
authorities so that their contributions are mainstreamed
into these and other health sector strategic documents.
In relation to this process, the private sector can provide
various data for National Health Management Informa-
tion Systems. Such information should include inputs
(expenditures on pharmaceutical and non-pharmaceuti-
cal supplies, number of health facilities, beds, clinical
technologies, and health workers); outputs (number of
inpatient admissions and discharges, number of preven-
tive and curative outpatient visits); and outcomes. The
private sector could also facilitate implementation of
national public health legislation and the International
Health Regulations [43].
Thrust 3: Supporting health systems strengthening based
on the Primary Health Care approach
The private sector has a contribution to make in
strengthening major components of national health sys-
tems, i.e. delivery of health services; health workforce;
health information; medical products, vaccines and tech-
nologies; and health financing [17].
Table 1 Broad and specific areas where private sector is expected to play a role
Broad thematic areas Specific areas Number of Regional Committee resolutions
HIV/AID, tuberculosis and malaria HIV/AIDS 5
Tuberculosis 4
Malaria 2
Prevention and control of other communicable diseases Trypanosomiasis 1
Dracunculiasis 5
Onchocerciasis 2
Cholera 1
Non-communicable disease prevention and control Cardiovascular diseases 1
Diabetes 1
Family and reproductive health Child health 2
EPI 1
Family planning 1
Maternal and newborn health 1
Health risk factors management Food safety 1
Nutrition 1
Iodine deficiency disorders 1
Health and development 2
Environmental sanitation 1
Tobacco 1
Health promotion 1
Health systems strengthening Essential medicines,
vaccines and technologies
5
E-Health 1
Information systems 1
Workforce 1
Health services 1
Health sector reforms 1
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health services are those which deliver effective, safe,
timely and quality personal and non-personal care to
those that need it with minimum waste [17]. In terms of
provision of health services, a government may leverage
the private sector to construct and maintain health facil-
ities; supply and maintain equipment; provide utilities
such as power, water and waste management services to
public facilities; provide catering, cleaning, laundry and
transport services to health facilities; and provide health
care to populations in remote areas. Governments can
also create an enabling policy and regulatory environ-
ment for the business community to invest in private
sector owned and managed health care enterprises, e.g.
private hospitals, clinics, and community-based health
promotion services.
Health workforce Ac o u n t r y ’s health workforce consists
broadly of health service providers and health manage-
ment and support workers. Most countries of the Afri-
can Region, especially the 36 that are in a health
workforce crisis [14], may require private sector support
in order to produce an adequate health workforce. This
may entail private sector partnering with public health
schools, medical schools, and schools of nursing. Such
public-private partnerships may mean that private edu-
cation institutions offer health training courses through
the public education system; receive public funds to
produce agreed quantities of human resources for
health; provide capital to individuals or groups to estab-
lish accredited private universities and colleges; and pay
public health training institutions to produce health
workforce for them or even for continuing education.
Health information A well-functioning health informa-
tion system is one that ensures the production, analysis,
dissemination and use of reliable and timely information
on health determinants, health systems performance and
health status [17]. The appreciation of the role of the
private sector partly hinges on the quality of information
submitted to the National Health Information System
(NHIS). However, the private sector in most countries
does not regularly provide data to the NHIS, and thus,
it is very difficult for ministries of health to generate evi-
dence for comprehensive health sector plans. Therefore,
in terms of health information, there is room for the
private sector to provide statistical information; make
relevant investments in eHealth infrastructure and ser-
vices; and fund or conduct biomedical and health sys-
tems research aimed at discovery or improvement of
health technologies and improvements in access to qual-
ity health care.
Medical products, vaccines and technologies A well-
functioning health system ensures equitable access to
essential medical products, vaccines and technologies of
assured quality, safety, efficacy and cost effectiveness,
and their scientifically sound and cost-effective use [17].
The private sector can complement government efforts
in improving health logistics in specific aspects such as
procurement and storage of medical products, vaccines
and other technologies as well as collaborate in the
enforcement of drug regulatory mechanisms and phar-
macovigilance. The latter entails collecting, monitoring,
researching, assessing and evaluating information from
healthcare providers and patients on the adverse effects
of medications, biological products, blood products, vac-
cines, medical devices, herbal medicines, and comple-
mentary and traditional medicines with a view to
identifying new information about hazards associated
with medicines and preventing harm to patients [64]. It
is important to emphasize that national governments
have a fundamental role in oversight and regulatory
matters.
Health financing A good health financing system raises
adequate funds for health to ensure that people who
needed health services are protected from any financial
catastrophe associated with having to pay for them [17].
Almost 50% of total health expenditures in the African
Region are from private spending; of which, approxi-
mately 71% of expenditures are from direct household
out-of-pocket payments to various health service provi-
ders. These direct payments are not pooled to share
financial risk, and thus, may expose a large proportion
of the population to financial catastrophe and impover-
ishment [65]. On matters of health financing, the private
sector can contribute in strengthening national health
financing strategies by assessing the economic feasibility
of prepaid health schemes, e.g. health insurance; devel-
oping or expanding coverage of private health insurance;
and paying premium contributions to national social
health insurance schemes for employees and families.
Thrust 3: Putting the health of mothers and children first
With regard to reducing maternal and newborn morbid-
ity and mortality, the private sector can play a role by
producing skilled birth attendants; increasing the num-
ber of private health facilities, especially in rural areas;
ensuring that private health facilities provide emergency
obstetric care and newborn plus child health services;
operating transport businesses, including ambulance ser-
vices, especially to refer patients and reduce delays in
accessing care; establishing micro-financing income-gen-
erating schemes, especially in rural areas and mainly for
women to improve their financial capacity; and broad-
casting Ministry of Health messages geared at modifying
deep-seated cultural practices that are detrimental to
women’s health, e.g. female genital mutilation, delivering
without assistance as an indicator of womanhood.
With regard to reductions in child morbidity and
mortality, the private health sector can ensure that facil-
ities provide at least a minimum package of
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insecticide-treated nets for pregnant women and infants;
antenatal care; neonatal care; complementary infant
feeding; oral rehydration therapy; malaria treatment;
management of pneumonia in newborns and children;
antiretroviral drugs for the management of paediatric
AIDS; and family planning services [22].
Thrusts 4 and 5: Accelerated actions on HIV/AIDS, malaria
and tuberculosis; and prevention and control of other
communicable and noncommunicable diseases
Concerning public health interventions for reducing the
burden of disease, the private sector can play an increas-
ing role in providing support to governments. Private
enterprise can produce and supply at affordable prices
quality-assured health technologies including laboratory
diagnostic tests; first-line and second-line medicines
[66,67]; and preventive supplies such as vaccines, con-
doms, intrauterine contraceptive devices, and long-last-
ing insecticide-treated nets.
To assist in the prevention and control of noncommu-
nicable diseases, the private sector can assist in imple-
menting the relevant articles of the WHO Framework
Convention on Tobacco Control [68]. The private sector
can promote physical activity by creating recreational
space when constructing commercial and residential
projects; providing pedestrian and cyclist pavements
when constructing roads; and investing in sports, recrea-
tion and leisure facilities, among others. Food industries
can promote healthy diets by reducing salt levels, elimi-
nating trans-fatty acids, decreasing saturated fats, limit-
ing free sugars [69] and providing accurate nutrition
facts. The private sector can contribute to the reduction
of harmful use of alcohol by avoiding sales to under-age
consumers; providing information on risks associated
with alcohol abuse; barring their employees from driving
or operating machinery while under the influence of
alcohol; and providing treatment for employees with
alcohol-use disorders. Finally, the private sector can
help perform environmental assessments of major con-
struction projects (e.g. dams, bridges, airports, ports, oil
drilling, irrigation schemes, etc) to ensure that negative
public health implications are duly identified and miti-
gated in a timely manner.
Thrust 6: Accelerating response to the determinants of
health
There is ample evidence that health is significantly influ-
enced by the socioeconomic conditions in which people
live, work and age, as well as the existing healthcare sys-
tems [57,70]. According to the WHO Commission on
Social Determinants of Health, these socioeconomic
conditions can help create or destroy human health
[70]. The private sector can contribute to improving the
social determinants of health through income and
wealth generation and distribution, early childhood care,
education, working conditions, job security, food secur-
ity, gender, housing, safe water and sanitation, and social
safety nets. These will play a vital role in improving the
health status of people. Therefore, addressing health
risks and determinants requires active participation
from all sectors.
Conclusion
The provision of health care within functional/well per-
forming health systems; and addressing challenges
related to broad determinants of health in the African
Region is too heavy for the public sector to tackle alone.
Given its breadth, scope and size, the private sector,
therefore, should play a more significant role in support-
ing government efforts to develop and implement
national health policies and strategic plans; strengthen
the national health systems; reduce maternal, newborn
and child morbidity and mortality; reduce the burden of
disease, i.e. communicable, noncommunicable and
neglected tropical diseases; and improve the broad
determinants of health.
All of the above should be done bearing in mind the
limited purchasing capacity of a significant proportion
of people in Africa. Merely increasing the supply of
health services is not sufficient for health development.
Governments and the private sector, among other health
stakeholders, will need to collaboratively manage the
quality, cost and access to health care and other key
determinants of health in order to improve health sta-
tus, quality of life and human development.
In conclusion, it is relevant to reiterate some of Hard-
ing’s discussion about private participation in health sys-
tems [71]. He identified three factors necessary for
harnessing the private sector to increase its role and
remain an effective player in health systems: knowledge
(on the part of policy-makers) about the private sector;
ongoing dialogue between public and private stake-
holders; and institutionalized policy instruments (espe-
cially financing, regulation, and information) for
interacting with the private sector. To fulfil these prere-
quisites, governments need to build capacities for plan-
ning, negotiation, oversight and regulation [72,73],
including those for regulation of prices, services, entitle-
ments, quality of care, health facility licensing, health
worker accreditation, medical audits, research, and clini-
cal protocols, to mention a few. In addition to legisla-
tion and other controls, governments can influence the
private sector through incentives and market structuring
[71].
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